Topical Catechin Composition for Sexual Function Without Hormonal Side Effects

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current treatments for female sexual disorders such as Genitopelvic Pain/Penetration Disorder, Sexual Interest/Arousal Disorder, and Female Orgasmic Disorder are ineffective, risky, or have significant side effects, and there is a lack of safe and effective treatments for male sexual disorders and cutaneous inflammation disorders.

Innovation Solution

The use of catechin compositions, particularly Epigallocatechin gallate, applied topically to genital areas to improve sexual function and treat disorders like Genitopelvic Pain/Penetration Disorder, Sexual Interest/Arousal Disorder, and Female Orgasmic Disorder, without estrogenic side effects, and also for treating cutaneous inflammation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If current treatments for female sexual disorders are used, then some symptomatic relief may be achieved, but significant side effects and risks occur

Engineering Contradiction:
Improvetreatment effectivenessVSAvoidside effects
Core Design Contradiction:
ReliabilityVSObject-affected harmful factors

Solution Approach 1:

The patent extracts and eliminates the harmful estrogenic components from existing treatments while retaining the beneficial effects on sexual function. The catechin composition provides therapeutic benefits without the systemic side effects associated with hormone-based treatments, directly resolving the contradiction between effectiveness and safety

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The invention uses topical catechin applications that act locally and temporarily without requiring long-term systemic hormone exposure. This approach provides effective symptom relief through short-term, localized treatment rather than continuous systemic therapy, reducing cumulative side effects while maintaining treatment reliability

Inventive Principle:
Principle #27Cheap short-living objects (Disposable)

2Ease of operation

If topical treatments are applied to improve sexual function, then sexual interest and arousal increase, but pain and discomfort may occur with certain compositions

Engineering Contradiction:
Improvesexual function improvementVSAvoidpain
Core Design Contradiction:
Ease of operationVSObject-affected harmful factors

Solution Approach 1:

The patent optimizes the concentration and formulation parameters of catechin compositions to achieve therapeutic effects without irritation. By carefully controlling the dosage and physical form of the topical application, the invention enhances sexual function while avoiding the pain and discomfort that can occur with improper formulation

Inventive Principle:
Principle #35Parameter changes

Solution Approach 2:

The invention uses homogeneous catechin compositions that provide consistent therapeutic effects across applications. The uniform formulation ensures predictable improvement in sexual function without variable irritation, resolving the contradiction between ease of operation and harmful factors

Inventive Principle:
Principle #33Homogeneity

3Productivity

If hormone-based treatments are used for sexual disorders, then sexual desire and arousal improve, but systemic side effects occur

Engineering Contradiction:
Improvesexual desireVSAvoidsystemic side effects
Core Design Contradiction:
ProductivityVSObject-generated harmful factors

Solution Approach 1:

The patent uses topical catechin as an intermediary substance that acts locally on genital tissues to improve sexual desire and arousal without entering systemic circulation. This localized mechanism of action provides the productivity benefits of hormone treatment while avoiding systemic side effects through the intermediary topical application method

Inventive Principle:
Principle #24Intermediary (Mediator)

Data Source

PatentUS20260076938A1Methods and compositions for treating male sexual disorders and improving sexual function
Publication Date: 2026.03.19 GTO PHARMA LLC
  • US20260076938A1 patent drawing
  • US20260076938A1 patent drawing
  • US20260076938A1 patent drawing

AI summary

The invention provides safe and efficacious treatments for the improvement of male and female sexual function, cutaneous inflammation such as psoriasis, eczema, dermatitis and Female Sexual Disorders, such as Genitopelvic Pain/Penetration Disorders; vulvovaginal atrophy, vestibulodynia, dyspareunia, Sexual Interest/Arousal Disorder, low female libido and Female Orgasmic Disorder.